HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Selection of a simian-human immunodeficiency virus strain resistant to a vaginal microbicide in macaques.

Abstract
PSC-RANTES binds to CCR5, inhibits human immunodeficiency virus type 1 (HIV-1) entry, and has been shown as a vaginal microbicide to protect rhesus macaques from a simian-human immunodeficiency virus chimera (SHIV(SF162-p3)) infection in a dose-dependent manner. In this study, env gene sequences from SHIV(SF162-p3)-infected rhesus macaques treated with PSC-RANTES were analyzed for possible drug escape variants. Two specific mutations located in the V3 region of gp120 (K315R) and C-helical domain of gp41 (N640D) were identified in a macaque (m584) pretreated with a 100 microM dose of PSC-RANTES. These two env mutations were found throughout infection (through week 77) but were found at only low frequencies in the inoculating SHIV(SF162-p3) stock and in the other SHIV(SF162-p3)-infected macaques. HIV-1 env genes from macaque m584 (env(m584)) and from inoculating SHIV(SF162-p3) (env(p3)) were cloned into an HIV-1 backbone. Increases in 50% inhibitory concentrations to PSC-RANTES with env(m584) were modest (sevenfold) and most pronounced in cells expressing rhesus macaque CCR5 as compared to human CCR5. Nonetheless, virus harboring env(m584), unlike inoculating virus env(p3), could replicate even at the highest tissue culture PSC-RANTES concentrations (100 nM). Dual-virus competitions revealed a dramatic increase in fitness of chimeric virus containing env(m584) (K315R/N640D) over that containing env(p3), but again, only in rhesus CCR5-expressing cells. This study is the first to describe the immediate selection and infection of a drug-resistant SHIV variant in the face of a protective vaginal microbicide, PSC-RANTES. This rhesus CCR5-specific/PSC- RANTES resistance selection is particularly alarming given the relative homogeneity of the SHIV(SF162-p3) stock compared to the potential exposure to a heterogeneous HIV-1 population in human transmission.
AuthorsDawn M Dudley, Jennifer L Wentzel, Matthew S Lalonde, Ronald S Veazey, Eric J Arts
JournalJournal of virology (J Virol) Vol. 83 Issue 10 Pg. 5067-76 (May 2009) ISSN: 1098-5514 [Electronic] United States
PMID19279098 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Anti-HIV Agents
  • Chemokine CCL5
  • RANTES, N(alpha)-(n-nonanoyl)-desSer(1)-(thioproline(2),cyclohexylglycine(3))-
  • RNA, Viral
  • env Gene Products, Human Immunodeficiency Virus
Topics
  • Animals
  • Anti-HIV Agents (pharmacology)
  • Cells, Cultured
  • Chemokine CCL5 (pharmacology)
  • Disease Models, Animal
  • Drug Resistance, Viral
  • Evolution, Molecular
  • Female
  • HIV Infections (virology)
  • HIV-1 (drug effects, genetics)
  • Humans
  • Macaca mulatta (virology)
  • Mutation
  • Polymorphism, Genetic
  • RNA, Viral (genetics)
  • Simian Immunodeficiency Virus (drug effects, genetics)
  • Vagina (virology)
  • env Gene Products, Human Immunodeficiency Virus (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: